- About CTTC
- Invention Disclosure
- News & Events
Four Vanderbilt inventions earn patent protection in December 2013
Jan 2 2014
Four Vanderbilt technologies earned patent protection from the USPTO in December, bringing the total number of patents assigned to Vanderbilt to 23 for the first half of FY14. The technologies include a new method for tumor detection, developed by Ray Mernaugh in the Biochemistry Department and Dennis Hallahan, formerly at VUMC; a new system for point-based rigid registration with anisotropic weighting developed by John Michael Fitzpatrick in the Department of Electrical Engineering and Computer Science; GBS toxin receptor compositions developed by Carl Hellerqvist from the Biochemistry Department and Changlin Fu; and a new compound that may be used to treat various neurological and psychiatric disorders that was developed by P. Jeffrey Conn and others at the Vanderbilt Center for Neuroscience Drug Discovery. Click the links below to read more.